menorrhagia. Excessive and frequent menstruation with regular cyc
Conditions
Interventions
Intervention 1: Intervention group: Persian Gulnar, 500mg, Q6h, days 1-5 of menstrual cycle. Intervention 2: Control group: Tranexamic acid, 500mg, Q6h, days 1-5 of menstrual cycle.
Treatment - Drugs
Intervention group: Persian Gulnar, 500mg, Q6h, days 1-5 of menstrual cycle
Control group: Tranexamic acid, 500mg, Q6h, days 1-5 of menstrual cycle
Sponsors
Research Asisstant of Tarbiat Modares University
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 20-45 years old, Regular menses, Heavy menstrual bleeding in several cycles, BMI 19-29 Exclusion criteria: Irregular menses or intra menstrual bleeding, Existence of uterine fibroids more than 3cm or other pathologic and iatrogenic causes for abnormal bleeding, Any systemic disease affecting menstrual bleeding, Using hormonal drugs (includes OCPs) or other drugs which influence menstrual bleeding, Having intra uterine device, Pregnancy, Anemia (Hb<10), any regimens for Iron deficiency
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual blood loss. Timepoint: one, two and three cycles after intervention. Method of measurement: by using pictorial blood assessment chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: before and after intervention. Method of measurement: by using Aberdeen Menorrhagia Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Azita Goshtasebi
Tarbiat Modares University
Outcome results
None listed